Results

Total Results: 185 records

Showing results for "adverse drug events".
Users also searched for: pressure injury

  1. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/professionals/education/curriculum-tools/teamstepps/officebasedcare/module1/1_ts_office_intro-ig.pptx
    January 20, 2006 - average severity of each delivery with an adverse event (Mann, Marcus, & Sachs, 2006); Reduced rate of adversedrug events; and Improved medication reconciliation at patient admission (Haig, Sutton, Whittington,
  2. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2019qdr-final-es-cs061721.pdf
    December 01, 2020 - Importance of Patient Safety Mortality Prevalence Cost Findings on Patient Safety Improving Trend: AdverseDrug Events With Heparin and Factor Xa Improving Trend: Inpatient Adverse Drug Events With Anticoagulants
  3. www.talkingquality.ahrq.gov/news/newsletters/e-newsletter/874.html
    August 01, 2023 - Articles featured this week include: Anticoagulation-associated adverse drug events in hospitalized
  4. www.talkingquality.ahrq.gov/news/newsletters/e-newsletter/884.html
    October 01, 2023 - Risk factors for opioid-related adverse drug events among older adults after hospitalization for major
  5. www.talkingquality.ahrq.gov/research/findings/studies/index.html?page=480
    January 01, 2024 - 1279) 2015 (1430) 2014 (662) 2013 (195) Topics Access to Care (417) AdverseDrug Events (ADE) (321) Adverse Events (736) Alcohol Use (61) Ambulatory Care and Surgery … Keywords: Opioids, Medication, Substance Abuse, Screening, Adverse Drug Events (ADE), Adverse Events
  6. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-213-section-5-table-4.pdf
    January 01, 2012 - CHIPRA 213: Section 5, Table 4 Table 4: Evidence Supporting Hydroxyurea Treatment for Children with Sickle Cell Disease TYPE OF EVIDENCE KEY FINDINGS LEVEL OF EVIDENCE (USPSTF RANKING*) CITATIONS Randomized controlled trial The Multicenter Study of Hydroxyurea in Sickle Cell Anemia (MSH), a ra…
  7. www.talkingquality.ahrq.gov/news/newsletters/e-newsletter/878.html
    August 01, 2023 - (Source: JAMA Network Open , Complications, Adverse Drug Events, High Costs, and Disparities in Multisystem
  8. www.talkingquality.ahrq.gov/research/findings/studies/index.html?page=1
    January 01, 2024 - 1279) 2015 (1430) 2014 (662) 2013 (195) Topics Access to Care (417) AdverseDrug Events (ADE) (321) Adverse Events (736) Alcohol Use (61) Ambulatory Care and Surgery … Keywords: Medication: Safety, Medication, Patient Safety, COVID-19, Adverse Drug Events (ADE), Adverse
  9. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2019qdr-datasources.pdf
    December 01, 2020 - MPSMS is composed of 21 measures representing six types of adverse drug events (ADEs); six types of … drug events 2004-2007 and 2009-2017 ADE - IV Heparin Adverse drug events 2004-2007 and 2009-2017 ADE … - Low Molecular Weight Heparin Adverse drug events 2004-2007 and 2009-2017 ADE - Warfarin Adverse drugevents 2004-2007 and 2009-2017 Catheter-Associated Urinary Tract Infection Infection 2005-2007 and … Adverse drug events among hospitalized Medicare patients: epidemiology and national estimates from a
  10. www.talkingquality.ahrq.gov/news/newsletters/e-newsletter/821.html
    June 01, 2022 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …
  11. www.talkingquality.ahrq.gov/news/newsletters/e-newsletter/index.html
    April 23, 2024 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …
  12. www.talkingquality.ahrq.gov/patient-safety/reports/liability/sands.html
    August 01, 2017 - Transitional Care Medication Safety: Stakeholders' Perspectives Medication Discrepancies and Potential AdverseDrug Events During Transfer of Care from Hospital to Home Kenneth E.F.
  13. www.talkingquality.ahrq.gov/patient-safety/reports/liability/waever.html
    August 01, 2017 - Transitional Care Medication Safety: Stakeholders' Perspectives Medication Discrepancies and Potential AdverseDrug Events During Transfer of Care from Hospital to Home Sallie J.
  14. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0217-section-5-table-5.pdf
    April 01, 2014 - Table 5. Evidence Supporting Emergency Department Pain Assessment for Children With Sickle Cell Disease Q‐METRIC SCD Measure 16, ED Pain Assessment U18HS020516 Page 1 Submitted April 2014 Table 5: Evidence Supporting Emergency Department Pain Assessment for Children with Sickle Cell Disease Type of Evi…
  15. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/engagingfamilies/strategy4/Strat4_Tool_1_IDEAL_chklst_508.pdf
    January 01, 2010 - of these could have been prevented or ameliorated.1 Common post-discharge complications include adversedrug events, hospital-acquired infections, and procedural complications.1 Many of these complications
  16. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/engagingfamilies/strategy4/Strat4_Tool_1_IDEAL_chklst_508.docx
    January 01, 2010 - three-quarters of these could have been prevented or ameliorated.1 Common post-discharge complications include adversedrug events, hospital-acquired infections, and procedural complications.1 Many of these complications
  17. www.talkingquality.ahrq.gov/patient-safety/settings/hospital/candor/modules/notes4.html
    August 01, 2022 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …
  18. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/aspirin-asa-measure.pptx
    April 01, 2016 - ABCS Aspirin Treatment for Secondary and Primary Prevention ASCVD ABCS Aspirin Treatment for Secondary and Primary Prevention ASCVD Jennifer Bannon RN BSN MSHI Table of Contents Objectives Cardiovascular Disease Cardiovascular Disease (2) ABCS-Aspirin when appropriate Anatomy of a Performance Measure Measure Exce…
  19. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/topics/public-notes-meeting-summary-031121.pdf
    July 22, 2021 - Federal Interagency Workgroup on Improving Diagnostic Safety and Quality 1 Federal Interagency Workgroup on Improving Diagnostic Safety and Quality in Health Care Workgroup Goal: Established by Senate Report 115-150. The Senate Committee on Appropriations requested “AHRQ to convene a cross agency working group t…
  20. www.talkingquality.ahrq.gov/patient-safety/patients-families/patient-family-engagement/index.html
    April 01, 2018 - Reconciliation Learn about the processes that help detect and prevent medication discrepancies and adversedrug events.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: